Company / Return on Assets (ROA)
aTYR PHARMA INC Return on Assets (ROA) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-79.7%
FY2025
5-year range
-79.7% / -16.9%
FY2021-FY2025
Trend
-20.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has declined for 3 consecutive years, from -16.9% in FY2022 to -79.7% in FY2025.
Based on SEC 10-K filings.
-79.7% in FY2025 with a 5-year CAGR of +9.4%.
Declined from -28.0% to -79.7% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -62.8pp
- 5-Year Change
- +9.4pp
- 10-Year Change
- -
Key checks
Key Insights
- aTYR PHARMA INC's return on assets (roa) has declined for 3 consecutive years.
- In FY2025, return on assets (roa) decreased 20.5% year-over-year.
- Peak return on assets (roa) was recorded in FY2022.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -79.7% | -20.5% |
| FY2024 | -66.1% | -136.2% |
| FY2023 | -28.0% | -65.2% |
| FY2022 | -16.9% | +17.1% |
| FY2021 | -20.4% | +77.1% |
| FY2020 | -89.1% | +33.1% |
| FY2019 | -133.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026